Astrazeneca stock: buy or sell
Apr 22nd, 2021
Astrazeneca stock brief
- Counting on Wednesday, it's been 3 consecutive sessions in positive for Astrazeneca. Price closed on Wednesday at $53.11 after rising a 1.61%.
- The price is currently above the upper Bollinger band, which is usually an indicator of a near-term correction
- Last Monday broke out above its latest top at $51.21
- From the chart point view, price is drawing a scaled uptrend since early March with higher tops and higher bottoms. This uptrend marked a 14.26% gain. Last Monday Astrazeneca broke out above $51.21 giving a buy point
- Argus published a neutral rating for Astrazeneca last Monday
Should I buy Astrazeneca stock?
All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best
Is $AZN stock a buy?
Currently, Astrazeneca stock matches one trading strategy:
Uptrend buy setup
Astrazeneca stock is in an uptrend since in early March that so far marked an amazing 14.00% gain. Price marked a local bottom in this uptrend at $48.26 on April 7, and since then it bounced up a 10.05%. Price just broke out above the entry point at $51.21, but it can be traded. If price goes beyond $53.77, it would be better to wait to another pullback. If you decide to enter this trade, the suggested stop loss is at $46.81
|Buy setup||Buy point||Stop loss||Risk|
|Uptrend buy setup||$51.21||$46.81||8.59%|
Should I sell Astrazeneca stock?
How to know when is it time to sell Astrazeneca?. Trading strategies allow us to avoid impulsive decisions based on our personal sentiments or the noise surrounding the market. When selling, as well as buying, detailed strategies are very easy to use and are only valid for selling shares you already own, not for shorting $AZN stock
A golden rule is that you should never keep an open trade that produces greater losses than those expected by the time of purchase. The timing to sell shares should always be determined by the stop-loss (automatic or manual)
Is it time to sell Astrazeneca stock?
In the current situation of Astrazeneca there is not any eligible sell setup, so Astrazeneca stock holders with operations in profit can keep their positions
In the last month, 3 analyst ratings were published for Astrazeneca
|Mar 23rd, 2021|
|Societe Generale|| |
|Apr 12th, 2021|
|Apr 19th, 2021|
Astrazeneca stock analysis
Since in early March, Astrazeneca has been drawing an uptrend that by now marked a gorgeous 14.26%. Rising peaks and troughs can be seen easily on a chart and how price action offered very few buy points on the breakouts. Latest pullback was on April 7, when price bounced at $48.26. Last Monday, Astrazeneca broke out above its last top ($51.21) giving a good entry point
Supports and resistances
The current resistance levels are:
The current support levels are:
When the price moves out of the band (above the upper line or below the lower line) it shows that the stock is currently maintaining a very strong momentum and therefore can reverse the trend to the average. At this point, the price is above the upper band, meaning a possible near-term adjustment (at least) until it is under the band
Relative strength index
When the fluctuates for so long below 70 and above 30, without showing moments of overvaluation and undervaluation, the indicator turns out to be of little use, and we find ourselves in one of these situations.
Astrazeneca stock price history
Astrazeneca went public priced at an adjusted price1 of $1.84 on May 1993. Since then, AZN stock surged by 2,786.41%, with an average of 103.20% per year. If you had invested thousand dollars in Astrazeneca stock at that time, it would have a value of $28,864.13 today.
1: Adjusted price after possible price splits or reverse-splits
Price target for Astrazeneca stock
Nobody can predict how much a share will be priced in the future. However, many stock price predictions are posted every day by banks, financial institutions and independent analysts.
Along with buy or sell recommendations, brokerage institutions post their price forecasts based on the stock price action and the company fundamental data. Most of these estimates follow the release of new financial information by the company, and usually. Again, these forecasts are not direct recommendations for individual traders and should not be followed blindly.
We don't have any target price published in the last month for Astrazeneca.
|Brokerage firm||Price target|
|Mar 23rd, 2021|
|Societe Generale||Not available|
|Apr 12th, 2021|
|Apr 19th, 2021|
Earnings and financials
Shareholders call was hosted by Astrazeneca ($AZN) last February after presenting the earnings report. Astrazeneca underperformed analysts estimates and presented of $0.54, that is a -20.59% worse than the previous estimates of $0.68. Instead, reported sales were $7.4 billion versus estimates of $7.0 billion.Compared to the same quarter one year ago, EPS was $0.45, so posted EPS is a increase of 20.00%. Looking at revenue, figures grew a 11.19% compared to $66.6B year over year.
Astrazeneca ($AZN) presents Q1 earnings report next Wednesday.
Disclaimer:The comments contained in this post are personal and should not be followed as recommendations for you to buy or sell shares. The author of this paper does not have any knowledge of the individual circumstances of the reader, his or her financial statements or what is in his or her best interest at any given time. All users should speak with their financial advisor before buying or selling any securities Comments are posted for learning motives only
|Wednesday, April 21st, 2021|
|Day range||$52.69 - $53.18|
|Average true range||$1.03|
|50d mov avg||$49.46|
|100d mov avg||$49.97|
|200d mov avg||$51.90|
|Earnings date||April 28th, 2021|